DFDS adds third ferry on Strait of Gibraltar route with Volcán de Tamasite acquisition
Bitget2026/10/08 12:45DFDS expanded its Strait of Gibraltar ferry network by acquiring Naviera Armas’ combined freight and passenger vessel Volcán de Tamasite. The deal adds a third ferry to the route, increasing capacity and operational flexibility for freight and passenger traffic. The vessel can carry 1,469 passengers plus 1,414 lane meters of freight. Volcán de Tamasite is expected to enter DFDS service from mid-November. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DFDS A/S published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
- DFDS expanded its Strait of Gibraltar ferry network by acquiring Naviera Armas’ combined freight and passenger vessel Volcán de Tamasite.
- The deal adds a third ferry to the route, increasing capacity and operational flexibility for freight and passenger traffic.
- The vessel can carry 1,469 passengers plus 1,414 lane meters of freight.
- Volcán de Tamasite is expected to enter DFDS service from mid-November.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
